文献速递流行病学与生物统计基础与转化研究

社区获得性肺炎的临床管理与研究建议

Community-acquired pneumonia.
PubMed 文献 · Lancet · 2021-01-01

社区获得性肺炎出院后1年内约三分之一患者死亡,公众重视不足。全球住院患者中高达18%存在至少一项免疫抑制危险因素,但该人群管理证据稀缺。本文综述成人社区获得性肺炎的临床管理要点,涵盖快速诊断、微生物学检查、并发症防治、经验性与个体化抗生素治疗、出院规划及长期随访,并提出临床与转化研究建议。

要点

  • 社区获得性肺炎出院后1年内约三分之一患者死亡,需重视长期随访。
  • 住院患者中高达18%存在免疫抑制危险因素,但该人群管理证据稀缺。
  • 管理要点包括快速诊断、微生物学检查、并发症防治及个体化抗生素治疗。

核心结论

  • 社区获得性肺炎死亡率高,需从快速诊断、微生物学检查、并发症防治、抗生素治疗、出院规划及长期随访等多方面优化临床管理以减少死亡和并发症。

研究设计与样本

  • 本文为综述(Seminar),提供成人社区获得性肺炎的更新观点及临床与转化研究建议。

主要发现

  • 社区获得性肺炎出院后1年内约三分之一患者死亡。
  • 全球住院社区获得性肺炎患者中高达18%存在至少一项免疫抑制危险因素。
  • 免疫抑制患者社区获得性肺炎管理的强证据稀缺。

关键数值与推荐

  • 经验性抗生素治疗应依据患者危险因素和当地微生物流行病学。
  • 个体化抗生素治疗应依据微生物学数据。
  • 应关注从静脉抗生素转为口服抗生素的适当结局指标。

临床怎么用

  • 对社区获得性肺炎患者应快速诊断并进行微生物学检查。
  • 应防治呼吸衰竭、脓毒症和多器官衰竭等并发症。
  • 应制定出院计划并进行长期随访。

局限性

  • 免疫抑制住院社区获得性肺炎患者管理的强证据稀缺。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Community-acquired pneumonia is not usually considered a high-priority problem by the public, although it is responsible for substantial mortality, with a third of patients dying within 1 year after being discharged from hospital for pneumoniae. Although up to 18% of patients with community-acquired pneumonia who were hospitalised (admitted to hospital and treated there) have at least one risk factor for immunosuppression worldwide, strong evidence on community-acquired pneumonia management in this population is scarce. Several features of clinical management for community-acquired pneumonia should be addressed to reduce mortality, morbidity, and complications related to community-acquired pneumonia in patients who are immunocompetent and patients who are immunocompromised. These features include rapid diagnosis, microbiological investigation, prevention and management of complications (eg, respiratory failure, sepsis, and multiorgan failure), empirical antibiotic therapy in accordance with patient's risk factors and local microbiological epidemiology, individualised antibiotic therapy according to microbiological data, appropriate outcomes for therapeutic switch from parenteral to oral antibiotics, discharge planning, and long-term follow-up. This Seminar offers an updated view on community-acquired pneumonia in adults, with suggestions for clinical and translational research.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Aliberti S, Dela Cruz CS, Amati F, et al. Community-acquired pneumonia. Lancet. 2021. PMID: 34481570. doi:10.1016/S0140-6736(21)00630-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。